TREM2 and neoplasm: Our results showed that CAR-T cells secreted PD-1-TREM2 scFV into the TME and that this approach resulted in superior anti-tumor efficacy relative to the treatment strategy involving CAR-T cells that secrete PD-1 scFv alone.